These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prostacyclin and thromboxane A2 release in isolated rat lungs. Korbut R, Boyd J, Eling T. Prostaglandins; 1982 Jan; 23(1):67-75. PubMed ID: 7038777 [Abstract] [Full Text] [Related]
23. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R, Nenci GG, Gresele P. J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [Abstract] [Full Text] [Related]
24. Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2. Caughey GE, Cleland LG, Gamble JR, James MJ. J Biol Chem; 2001 Oct 12; 276(41):37839-45. PubMed ID: 11483590 [Abstract] [Full Text] [Related]
25. Modulation of rat platelet activation by vessel wall-derived prostaglandin and platelet-derived thromboxane: effects of dietary fish oil on thromboxane-prostaglandin balance. Nieuwenhuys CM, Feijge MA, Offermans RF, Kester AD, Hornstra G, Heemskerk JW. Atherosclerosis; 2001 Feb 01; 154(2):355-66. PubMed ID: 11166768 [Abstract] [Full Text] [Related]
34. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. Weir MR, Sperling RS, Reicin A, Gertz BJ. Am Heart J; 2003 Oct 01; 146(4):591-604. PubMed ID: 14564311 [Abstract] [Full Text] [Related]
35. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors. Vitale P, Tacconelli S, Perrone MG, Malerba P, Simone L, Scilimati A, Lavecchia A, Dovizio M, Marcantoni E, Bruno A, Patrignani P. J Med Chem; 2013 Jun 13; 56(11):4277-99. PubMed ID: 23651359 [Abstract] [Full Text] [Related]